1Cell.Ai - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2021, 1Cell.Ai operates in Health Tech offering precision oncology liquid biopsy diagnostics through the development of CTC-based, single-cell multi-omics lab developed tests. The company f...
Funding stage:
Series A
Last funding:
21/11/2024
Total funding:
$16.00 Mn+
Revenue:
Investors
1Cell.Ai: Funding Highlights
Funding highlights of 1Cell.Ai and a snapshot of its key metrics.
Total Funding$16.00 Mn+
Current StageGrowth Stage
Total Round(s)1
Funding Rounds
FAQs on Funding of 1Cell.Ai
Health Tech Funded 1Cell.Ai has raised a total funding of $16.00 million as of 22 November 2024 across 1 rounds. Find the details around funding rounds, participating investors, and other insights of 1Cell.Ai here...
1Cell.Ai has raised a total of $16.00 million across 1 funding rounds and the last round was raised on 22 November 2024.
1Cell.Ai's key investors include Cedars Sinai, Celesta Capital, Eragon and 2 others.
1Cell.Ai's latest funding round was $16.00 million in Growth Stage, raised on 22 November 2024.
1Cell.Ai is at the Growth stage. Its most recent round was raised on 22 November 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links